FILANA THERAPEUTICS, INC. - Common Stock (FLNA)
CUSIP: 14817C107
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 48,331,225
- Total 13F shares
- 3,351,011
- Share change
- +8,826
- Total reported value
- $4,055,000
- Price per share
- $1.21
- Number of holders
- 20
- Value change
- +$2,993
- Number of buys
- 8
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 14817C107?
CUSIP 14817C107 identifies FLNA - FILANA THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 14817C107:
Top shareholders of FLNA - FILANA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| First Eagle Investment Management, LLC |
13F
|
Company |
3.5%
|
1,696,181
|
$2,188,000 | — | 31 Mar 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.2%
|
583,892
|
$753,000 | — | 31 Mar 2019 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.6%
|
288,363
|
$372,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.46%
|
223,969
|
$289,000 | — | 31 Mar 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.36%
|
175,342
|
$226,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
66,068
|
$85,000 | — | 31 Mar 2019 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.13%
|
64,415
|
$83,000 | — | 31 Mar 2019 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.11%
|
50,788
|
$66,000 | — | 31 Mar 2019 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.08%
|
39,919
|
$51,000 | — | 31 Mar 2019 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.08%
|
39,082
|
$50,000 | — | 31 Mar 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
22,105
|
$29,000 | — | 31 Mar 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
20,731
|
$27,000 | — | 31 Mar 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
18,684
|
$24,000 | — | 31 Mar 2019 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
14,285
|
$18,000 | — | 31 Mar 2019 | |
| CWM, LLC |
13F
|
Company |
0%
|
200
|
$17,000 | — | 31 Mar 2019 | |
| Virtu Financial LLC |
13F
|
Company |
0.03%
|
12,134
|
$16,000 | — | 31 Mar 2019 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
10,558
|
$14,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
6,715
|
$9,000 | — | 31 Mar 2019 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
3,148
|
$4,000 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
2,232
|
$3,000 | — | 31 Mar 2019 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
2,200
|
$3,000 | — | 31 Mar 2019 | |
| Financial Architects, Inc |
13F
|
Company |
0%
|
700
|
$1,000 | — | 31 Mar 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
674
|
$1,000 | — | 31 Mar 2019 |
Institutional Holders of FILANA THERAPEUTICS, INC. - Common Stock (FLNA) as of Q2 2019
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.